Featured news
-
Upcoming East Region Paediatric and Prenatal Genomics Forums
Below you can find more information and registration links for our upcoming East Genomics Forums for Paediatrics (25 July) and Prenatal (16 September).
-
Monogenic Diabetes in Maternity: Educational and networking event for maternity diabetes teams
This event is free to attend for clinicians from the East of England and East Midlands.
-
Whole genome sequencing ‘game changer’ for diagnosis and personalised treatment of adult cancer patients
New research shows that a specific form of genetic test – known as whole genome sequencing, or WGS for short – is invaluable in patients with a certain type of cancer that is difficult to diagnose and treat.
-
Cutting-edge genomic test can improve care of children with cancer
Cambridge researchers say a genetic test offered by the NHS improved clinical care of children with cancer, and should be provided to all children with cancer.
-
Invitation to our Monogenic Diabetes in Maternity mid-point project update
A meeting to update maternity diabetes service leads on scoping work in the East region, around introducing testing for glucokinase hyperglycaemia within the gestational diabetes care pathway.
-
Ride for Rare - help us raise funds to support people and families affected by rare genetic conditions
On Sunday 15 September 2024, teams of healthcare and genetics professionals will embark on bike rides around Nottingham and Cambridge to raise money for charities supporting people with rare genetic conditions.
All news
Showing 20 results
Webinar: Lynch Syndrome Management
This webinar has been organised by the East Genomic Medicine Service Alliance (East GMSA). It is aimed at all clinicians, nurses, managers & coordinators in primary and secondary care who work with patients with Lynch Syndrome.
Rachel's story: Genomics helped me understand my cancer
Rachel Gilbert was diagnosed with gastrointestinal stromal tumours (GIST) aged 15 and says whole genome sequencing has provided vital answers for her and her family.
How is genomics changing pharmacy?
Genomics is starting to have a huge impact on pharmacy. Recently, genomics is being used to predict how an individual will handle specific drugs to reduce harm and improve outcomes.
Familial Cancer Specialists - a unique team supporting patients with suspected inherited cancer
Wendy Chorley is the Lead Familial Cancer Specialist at University Hospitals of Derby and Burton NHS Foundation Trust. She leads a team of five familial cancer specialists, most of whom are nurses or allied health professionals.
The role of genomics in midwifery
For Genomics Conversation Week 2022, Angela Crosby, Antenatal and Newborn Screening Coordinator, United Lincolnshire Hospitals NHS Trust (ULHT), talks about the role of her team and the impact genomics has in their work.
The importance of identifying patients with Monogenic Diabetes
For Diabetes Week (13 - 19 June), Anita Murphy, our regional Genetic Diabetes Nurse - East Midlands and East of England - has shared with us why it is important for clinicians to consider this type of diabetes when seeing patients and how it can change th
Nursing and midwifery team appointed to help peers across the region take a proactive role in genomic medicine
The recently appointed nursing and midwifery staff at East Genomics are an essential part of the strategic team to support the mainstreaming of genomic medicine into clinical practice across the East of England and East Midlands to help improve patient care and outcomes.
New genomic testing provides vital diagnosis for severely ill babies
Cambridge research suggests more than a third of severely sick babies given rapid whole genome sequencing have received a vital genetic diagnosis.
More than 100 children with cancer across the East of England benefit from whole genome sequencing
In a significant milestone, more than 100 children with cancer from across the East of England have had their tumours tested by whole genome sequencing (WGS) and interpreted by scientists in the NHS Genomic Medicine Service at Cambridge University Hospitals NHS Foundation Trust (CUH), to help improve their diagnosis and treatment.
Largest study of whole genome sequencing data reveals new causes of cancer
Cambridge analysis of more than 12,000 tumours from NHS patients has found DNA evidence of over 50 new potential causes of cancer.
Revolutionary new treatment path for patients with aggressive brain tumours
Brain tumour patients at Addenbrooke’s Hospital in Cambridge are the first in the UK to benefit from personalised treatment using the latest advances in genomics and targeted therapies through the Minderoo Foundation's new Precision Brain Tumour Programme (MPBTP).
Genetic testing for Lynch syndrome help patients and clinicians fight cancer
Awareness of this inherited condition can help patients alert relatives to get tested and it can also ensure suitable screening and preventative treatment for future cancers
With a history of cancer in the family, Marla's story highlights how a Lynch syndrome diagnosis has helped her
Marla explains how she can look forward and concentrate on the prevention of cancer for herself and her family since her Lynch syndrome diagnosis
Genetic study gives new insights into severe Covid
The world’s largest genetic study of critically-ill Covid patients, involving more than 200 treated at Addenbrooke's, reveals extensive insights into the disease.
Family share Eilidh's story on Rare Disease Day
Raising a child with a rare or little understood condition is a major challenge for parents.
E-learning modules launched to help clinicians across the region order genomic tests for patients
Clinical Geneticists and Genetic Counsellors at Cambridge University Hospitals (CUH) have developed several short e-learning modules to help healthcare professionals across the East of England and East Midlands offer genomic testing to patients.
Cambridge clinician wins funding to safely link big datasets to help find medical answers
Cambridge researchers are to trial methods of analysing data across more than one secure research environment – something which has previously not been possible, but which could be of great benefit to the public once established.
Whole genome sequencing improves diagnosis of rare diseases and shortens diagnostic journeys for patients, according to world first study
A world-first scientific study has shown that whole genome sequencing (WGS) can uncover new diagnoses for people across the broadest range of rare diseases investigated to date
Whole Genome Sequencing helps doctors treat Daniel’s rare cancer
Sport-loving schoolboy Daniel is back on the football pitch following precision treatment of a rare kidney tumour
Serena Nik-Zainal wins top prize for ground-breaking research into cancer
Professor Serena Nik-Zainal has been announced as the winner of the 2021 Foulkes Foundation Academy of Medical Sciences Medal